The genomic landscape of small intestine neuroendocrine tumors
about
Notch Signaling in Neuroendocrine TumorsSmall bowel neuroendocrine tumors: From pathophysiology to clinical approachThe PI3K/Akt Pathway in Tumors of Endocrine TissuesApplication and Dosimetric Requirements for Gallium-68-labeled Somatostatin Analogues in Targeted Radionuclide Therapy for Gastroenteropancreatic Neuroendocrine TumorsAdvances in small bowel neuroendocrine neoplasiaBRAFV600E Mutations in High-Grade Colorectal Neuroendocrine Tumors May Predict Responsiveness to BRAF-MEK Combination Therapy.Summary of emerging personalized medicine in neuroendocrine tumors: are we on track?Predicting the survival of patients with small bowel neuroendocrine tumours: comparison of 3 systems.Gene network-based analysis identifies two potential subtypes of small intestinal neuroendocrine tumors.Clinical biomarkers of pulmonary carcinoid tumors in never smokers via profiling miRNA and target mRNACadherin 17 is frequently expressed by 'sclerosing variant' pancreatic neuroendocrine tumourCopy number alterations in small intestinal neuroendocrine tumors determined by array comparative genomic hybridizationLiver metastases of small intestine neuroendocrine tumors: Ki-67 heterogeneity and World Health Organization grade discordance with primary tumorsCombined comparative genomic hybridization and transcriptomic analyses of ovarian granulosa cell tumors point to novel candidate driver genes.A Hereditary Form of Small Intestinal Carcinoid Associated With a Germline Mutation in Inositol Polyphosphate Multikinase.A Selected Lactobacillus rhamnosus Strain Promotes EGFR-Independent Akt Activation in an Enterotoxigenic Escherichia coli K88-Infected IPEC-J2 Cell Model.High-Level HOOK3 Expression Is an Independent Predictor of Poor Prognosis Associated with Genomic Instability in Prostate CancerA plausible role for actin gamma smooth muscle 2 (ACTG2) in small intestinal neuroendocrine tumorigenesisGenomic Characterization of Poorly Differentiated Neuroendocrine Carcinoma in a Pediatric PatientFunctional malignant cell heterogeneity in pancreatic neuroendocrine tumors revealed by targeting of PDGF-DDA Genome-Wide Association Study of Cutaneous Squamous Cell Carcinoma among European Descendants.Somatic alterations of CDKN1B are associated with small bowel neuroendocrine tumors.A Delphic consensus assessment: imaging and biomarkers in gastroenteropancreatic neuroendocrine tumor disease managementIntegrative genetic characterization and phenotype correlations in pheochromocytoma and paraganglioma tumours.Decoding the Molecular and Mutational Ambiguities of Gastroenteropancreatic Neuroendocrine Neoplasm Pathobiology.Gastroenteropancreatic neuroendocrine tumors: recommendations of Turkish multidisciplinary neuroendocrine tumor study group on diagnosis, treatment and follow-up.Clinical application of microRNA testing in neuroendocrine tumors of the gastrointestinal tract.Nuclear imaging of neuroendocrine tumors with unknown primary: why, when and how?DNA methylation profiles distinguish different subtypes of gastroenteropancreatic neuroendocrine tumors.Current Perspective on the Pathogenesis of Small Intestinal Neuroendocrine Tumors: Progress in Biomarkers and Molecular Events.Everolimus for the treatment of advanced, non-functional neuroendocrine tumours of the lung or gastrointestinal tract (RADIANT-4): a randomised, placebo-controlled, phase 3 study.The selective PI3Kα inhibitor BYL719 as a novel therapeutic option for neuroendocrine tumors: Results from multiple cell line models.mTOR inhibitors activate PERK signaling and favor viability of gastrointestinal neuroendocrine cell lines.Divergent clonal evolution of castration-resistant neuroendocrine prostate cancer.Genetics and epigenetics in small intestinal neuroendocrine tumours.NONO regulates the intra-S-phase checkpoint in response to UV radiation.Translational research in neuroendocrine tumors: pitfalls and opportunities.Expression profiling of small intestinal neuroendocrine tumors identifies subgroups with clinical relevance, prognostic markers and therapeutic targets.Association between the functional polymorphism Ile31Phe in the AURKA gene and susceptibility of hepatocellular carcinoma in chronic hepatitis B virus carriers.Enteroendocrine cells-sensory sentinels of the intestinal environment and orchestrators of mucosal immunity.
P2860
Q26752380-AC267648-4E7F-44C3-9940-A7B49AAF8022Q26766650-F6AD12AF-97B5-48E3-A60A-ECB04401B5C5Q26770404-AFB854DC-6918-4964-A69F-8D23DE0A1580Q26783272-D2E85706-D3A8-4A89-8FB1-6E69B03C3CBEQ27000397-15D0FBBD-E519-4654-8CAA-6F513BA746EEQ27853371-D395AFE1-6B15-4F0B-BE46-012AC8B38270Q28078610-A54C91BC-6536-4288-A20F-FDB9A60DF588Q33656484-BBCF8D7B-DBC3-4664-B866-86B059D87778Q34012005-5C32D023-F82B-4DA2-A18C-CC90B0C887DBQ34013428-C4D229F4-C4A2-41F7-B60E-3EC76B2ECA49Q34995751-81C27A6F-357C-4D6B-837B-DAED11141DBBQ35027292-C13BAE3D-E41E-434E-BE0A-7ADA5AC56BE0Q35163126-FDB529AC-9700-4532-942F-105679451DF1Q35531774-E630ECBB-D97F-45E7-98DA-73DFD11CEEB9Q35599795-A6745576-99F1-4C1A-8F63-25A683CA90F5Q35615534-E840E562-24C7-4B20-A86E-591D238C861BQ35731092-FE601F8F-5837-4902-B2FB-A1E62DDC8376Q35997446-EF6888B4-90AF-4D7A-97A4-9C9B5626AE4DQ36378094-2FF08131-6F01-4207-9E2A-888DC90132EEQ36607541-FD1F001B-E801-4E4F-8E4A-604FC26B0D1FQ36917793-8F9C899D-5872-4B97-BDDC-A40873CD175CQ37075351-DFF29C84-4F82-4625-92C2-57358784FDD3Q37302087-D00F2FD0-14BA-46C3-92FA-58B068A968C4Q37505830-7CE65FAA-01A2-46A4-A3CE-A79CA5041546Q37634917-FE1837C7-EB7C-41A8-B125-3EE74A045CF9Q37675588-D196C658-54B1-4F4B-8F83-01470D8517C9Q38190817-816B258F-01E0-46B9-B0BF-18811480FA4FQ38378364-829F93FF-EFD7-4D1E-BCB8-C02817C5DF12Q38457942-147B19DB-6892-48EB-A821-FDC158498596Q38671031-F334331F-5517-468C-BB03-9DB9F8BB9192Q38679359-75FC28BF-5043-4219-ACB6-018D53925EDFQ38695102-A1869557-4F9C-41C1-8E59-7901084DFAE8Q38706917-3F41ED5D-365D-484C-8EC2-A35E85C29114Q38768101-32040510-FFC1-494F-945B-739C7A318CC3Q38866281-3F2C7365-F3D7-4D48-928D-9EF43705D3BAQ38884670-A3CEECFB-AF90-4BA5-8432-95D6911ECC72Q38958002-739FC761-057A-403E-AA1B-F680851B4340Q39930415-3991155C-93B0-4141-ACFD-8F25C1157DC7Q40043160-5A768302-2B2F-4DF3-9DF8-0AC26FC13456Q40074896-3EC78CF9-39E8-4BFE-800B-113EAD53C792
P2860
The genomic landscape of small intestine neuroendocrine tumors
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年学术文章
@wuu
2013年学术文章
@zh-cn
2013年学术文章
@zh-hans
2013年学术文章
@zh-my
2013年学术文章
@zh-sg
2013年學術文章
@yue
2013年學術文章
@zh
2013年學術文章
@zh-hant
name
The genomic landscape of small intestine neuroendocrine tumors
@en
type
label
The genomic landscape of small intestine neuroendocrine tumors
@en
prefLabel
The genomic landscape of small intestine neuroendocrine tumors
@en
P2093
P2860
P356
P1476
The genomic landscape of small intestine neuroendocrine tumors
@en
P2093
Amit A Kulkarni
Andreas S Beutler
Benjamin R Kipp
Bruce W Eckloff
David M Nagorney
Eric D Wieben
Erik C Thorland
Franziska Metge
Ganesh K Boora
Judith A Gilbert
P2860
P304
P356
10.1172/JCI67963
P407
P577
2013-05-15T00:00:00Z